147
Participants
Start Date
April 30, 2014
Primary Completion Date
January 31, 2019
Study Completion Date
August 31, 2020
Cisplatin
Paclitaxel
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center-Sleepy Hollow, Sleepy Hollow
Memorial Sloan Kettering Cancer Center-West Harrison, Harrison
Memorial Sloan Kettering Cancer Center-Rockville Centre, Rockville Centre
Memorial Sloan Kettering Cancer Center-Commack, Commack
Universtiy of Pittsburgh- Magee-Womens Hospital, Pittsburgh
Johns Hopkins University, Baltimore
University of North Carolina- Lineberger Cancer Center, Chapel Hill
Duke University, Durham
University of Alabama, Birmingham
Vanderbilt-Ingram Cancer Center, Nashville
Indiana University- Simon Cancer Center, Indianapolis
Baylor College of Medicine, Houston
Seattle Cancer Alliance at EvergreenHealth, Kirkland
University of Washignton, Seattle
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
South Shore Hospital, Weymouth
Memorial Sloan Kettering Cancer Center-Basking Ridge, Basking Ridge
Memorial Sloan Kettering Cancer Center-Monmouth, Middletown
Collaborators (1)
Myriad Genetics, Inc.
INDUSTRY
Translational Breast Cancer Research Consortium
OTHER
Dana-Farber Cancer Institute
OTHER